EP2277538 - Combined meningitis vaccines [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 24.01.2020 Database last updated on 03.09.2024 | |
Former | Examination is in progress Status updated on 06.03.2019 | Most recent event Tooltip | 24.01.2020 | Application deemed to be withdrawn | published on 26.02.2020 [2020/09] | Applicant(s) | For all designated states GlaxoSmithKline Biologicals s.a. rue de l'Institut 89 1330 Rixensart / BE | [2017/37] |
Former [2011/27] | For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH | ||
Former [2011/04] | For all designated states Novartis Vaccines and Diagnostics S.r.l. Via Fiorentina 1 53100 Siena (SI) / IT | Inventor(s) | 01 /
Contorni, Mario c/o Novartis Vaccines Via Fiorentina 1 53100 Siena / IT | [2011/04] | Representative(s) | Dalton, Marcus Jonathan William, et al GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | [N/P] |
Former [2011/04] | Marshall, Cameron John Carpmaels & Ransford One Southampton Row London WC1B 5HA / GB | Application number, filing date | 10180408.6 | 04.10.2004 | [2011/04] | Priority number, date | GB20030023102 | 02.10.2003 Original published format: GB 0323102 | GB20040012052 | 28.05.2004 Original published format: GB 0412052 | [2011/04] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2277538 | Date: | 26.01.2011 | Language: | EN | [2011/04] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 17.12.2010 | Classification | IPC: | A61K39/095, A61K39/102, A61K39/09 | [2011/04] | CPC: |
A61K39/095 (EP,US);
A61K9/19 (US);
A61K39/102 (EP,US);
A61K39/39 (EP,US);
A61K47/646 (EP,US);
A61P25/00 (EP);
A61P31/04 (EP);
A61P31/12 (EP);
A61P37/04 (EP);
A61K2039/55505 (EP,US);
A61K2039/6037 (EP,US);
A61K2039/6068 (EP,US);
A61K2039/70 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2011/04] | Title | German: | Kombinationsimpfstoffe gegen Meningitis | [2011/04] | English: | Combined meningitis vaccines | [2011/04] | French: | Vaccins combinés contre la méningite | [2011/04] | Examination procedure | 26.07.2011 | Examination requested [2011/35] | 11.11.2011 | Amendment by applicant (claims and/or description) | 23.05.2012 | Despatch of a communication from the examining division (Time limit: M06) | 19.03.2013 | Reply to a communication from the examining division | 09.04.2014 | Despatch of a communication from the examining division (Time limit: M11) | 24.06.2015 | Reply to a communication from the examining division | 11.03.2019 | Despatch of a communication from the examining division (Time limit: M06) | 24.09.2019 | Application deemed to be withdrawn, date of legal effect [2020/09] | 18.10.2019 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2020/09] | Parent application(s) Tooltip | EP04791703.4 / EP1670506 | EP08075538.2 / EP1961426 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20040791703) is 13.06.2007 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 24.06.2015 | Request for further processing filed | 24.06.2015 | Full payment received (date of receipt of payment) Request granted | 17.07.2015 | Decision despatched | The application is deemed to be withdrawn due to failure to reply to the examination report | 19.03.2013 | Request for further processing filed | 19.03.2013 | Full payment received (date of receipt of payment) Request granted | 04.04.2013 | Decision despatched | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 11.11.2011 | Request for further processing filed | 11.11.2011 | Full payment received (date of receipt of payment) Request granted | 25.11.2011 | Decision despatched | Fees paid | Renewal fee | 27.09.2010 | Renewal fee patent year 03 | 27.09.2010 | Renewal fee patent year 04 | 27.09.2010 | Renewal fee patent year 05 | 27.09.2010 | Renewal fee patent year 06 | 27.09.2010 | Renewal fee patent year 07 | 11.10.2011 | Renewal fee patent year 08 | 11.10.2012 | Renewal fee patent year 09 | 14.10.2013 | Renewal fee patent year 10 | 14.10.2014 | Renewal fee patent year 11 | 07.10.2015 | Renewal fee patent year 12 | 07.10.2016 | Renewal fee patent year 13 | 10.10.2017 | Renewal fee patent year 14 | 05.10.2018 | Renewal fee patent year 15 | 08.10.2019 | Renewal fee patent year 16 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO0200249 (SMITHKLINE BEECHAM BIOLOG [BE], et al) [X] 1-15 * page 7, line 14 - page 8, line 33; examples 2,3 *; | [XP]WO2004067030 (CHIRON SRL [IT], et al) [XP] 1-15 * page 1, line 30 - page 2, line 21 * * page 10, line 35 - page 11, line 19 * * page 27, line 14 - line 29 ** page 34, line 15 - line 18 *; | [A] - CRIPPS A W ET AL, "Challenges for the development of vaccines against Haemophilus influenzae and Neisseria meningitidis", CURRENT OPINION IN IMMUNOLOGY, CURRENT BIOLOGY LTD, (20021001), vol. 14, no. 5, ISSN 0952-7915, pages 553 - 557, XP004377406 [A] 1-15 * page 554, column R, paragraph 2 - page 555, column L, paragraph 1 * * page 555, column L, paragraph 3 * * page 555, column L, paragraph L - column R, paragraph 1 * DOI: http://dx.doi.org/10.1016/S0952-7915(02)00373-4 | [A] - PELTOLA H, "Prophylaxis of bacterial meningitis.", INFECTIOUS DISEASE CLINICS OF NORTH AMERICA SEP 1999, (199909), vol. 13, no. 3, ISSN 0891-5520, pages 685 - 710 , vii, XP000999602 [A] 1-15 * page 689, paragraph 4 - page 693, paragraph 5 * * page 701, paragraph 2 - page 702, paragraph 1 * * page 704, paragraph 3 - paragraph 4 * DOI: http://dx.doi.org/10.1016/S0891-5520(05)70101-X | Examination | WO2004032958 | by applicant | US4057685 | US4356170 | EP0109942 | US4459286 | EP0208375 | US4663160 | US4673574 | US4695624 | US4761283 | US4808700 | US4882317 | EP0372501 | EP0378881 | US4965338 | WO9014837 | WO9101146 | EP0427347 | US5057540 | EP0471177 | WO9203467 | EP0477508 | WO9306861 | WO9317712 | WO9324148 | WO9400153 | WO9403208 | EP0586266 | WO9405325 | US5306492 | EP0594610 | EP0626169 | WO9508348 | US5425946 | WO9517211 | EP0689454 | WO9611711 | WO9614086 | EP0735898 | WO9633739 | WO9637222 | WO9640242 | WO9700697 | EP0761231 | EP0835318 | WO9840100 | WO9842721 | WO9842375 | WO9857659 | WO9858668 | WO9911241 | WO9924578 | WO9927960 | US5912336 | WO9931132 | US5916588 | WO9936544 | WO9940936 | WO9942130 | WO9944636 | WO9952549 | WO9957280 | WO9958683 | WO9962923 | WO0007621 | WO0010599 | WO0022430 | WO0038711 | US6090406 | WO0056360 | WO0056365 | WO0061761 | WO0066741 | US6146902 | US6207646 | WO0121207 | WO0121152 | WO0130390 | US6239116 | WO0164920 | WO0164922 | WO0172337 | WO0195935 | US6333036 | WO0200249 | WO0222167 | WO0226757 | WO02058737 | US6429199 | WO02091998 | US6495345 | WO03007985 | WO03010194 | WO03009869 | WO03020756 | WO03024480 | WO03024481 | WO03035836 | WO03063766 | WO03080678 | WO2004014419 | WO2004015099 | WO2004014418 | WO2004032958 | WO2004048404 | WO2004083251 | WO2005033148 | - DARKES; PLOSKER, PAEDIATR DRUGS, (2002), vol. 4, pages 609 - 630 | - JONES, CURR OPIN INVESTIG DRUGS, (2001), vol. 2, pages 47 - 49 | - ARMAND ET AL., J. BIOL. STAND., (1982), vol. 10, pages 335 - 339 | - CADOZ ET AL., VACCINE, (1985), vol. 3, pages 340 - 342 | - BAKLAIC ET AL., INFECT. IMMUN., (1983), vol. 42, pages 599 - 604 | - MMWR, (1997), vol. 46, no. RR-5, pages 1 - 10 | - BJUNE ET AL., LANCET, (1991), vol. 338, no. 8775, pages 1093 - 96 | - FRASH, Advances in Biotechnological Processes, (1990), vol. 13, pages 123 - 145 | - INZANA, INFECT. IMMUN., (1987), vol. 55, pages 1573 - 1579 | - KANDIL ET AL., GLYCOCONJ J, (1997), vol. 14, pages 13 - 17 | - BERKIN ET AL., CHEMISTRY, (2002), vol. 8, pages 4424 - 4433 | - GLODE ET AL., J INFECT DIS, (1979), vol. 139, pages 52 - 56 | - NILSSON; SVENSSON, CARBOHYDRATE RESEARCH, (1979), vol. 69, pages 292 - 296 | - RAMSAY ET AL., LANCET, (2001), vol. 357, no. 9251, pages 195 - 196 | - LINDBERG, VACCINE, (1999), vol. 17, no. 2, pages S28 - 36 | - BUTTERY; MOXON, JR COLL PHYSICIANS LOND, (2000), vol. 34, pages 163 - 168 | - AHMAD; CHAPNICK, INFECT DIS CLIN NORTH AM, (1999), vol. 13, pages 113 - 133 | - GOLDBLATT, J. MED. MICROBIOL., (1998), vol. 47, pages 563 - 567 | - Conjugate Vaccines, vol. 10, pages 48 - 114 | - ANONYMOUS, RESEARCH DISCLOSURE, (200201), page 453077 | - ANDERSON, INFECT IMMUN, (1983), vol. 39, no. 1, pages 233 - 238 | - ANDERSON ET AL., J CLIN INVEST, (1985), vol. 76, no. 1, pages 52 - 59 | - FALUGI ET AL., EUR J IMMUNOL, (2001), vol. 31, pages 3816 - 3824 | - BARALDO ET AL., INFECT IMMUN., (2004), vol. 72, pages 4884 - 7 | - KUO ET AL., INFECT IMMUN, (1995), vol. 63, pages 2706 - 13 | - LEES ET AL., VACCINE, (1996), vol. 14, pages 190 - 198 | - PORRO ET AL., MOL IMMUNOL, (1985), vol. 22, pages 907 - 919 | - GEVER ET AL., MED. MICROBIOL. IMMUNOL, (1979), vol. 165, pages 171 - 288 | - LEI ET AL., DEV BIOL (BASEL), (2000), vol. 103, pages 259 - 264 | - LAMB ET AL., DEV BIOL (BASEL), (2000), vol. 103, pages 251 - 258 | - LAMB ET AL., JOURNAL OF CHROMOTOGRAPHY A, (2000), vol. 894, pages 311 - 318 | - D'AMBRA ET AL., DEV BIOL (BASEL), (2000), vol. 103, pages 241 - 242 | - RAVENSCROFT ET AL., VACCINE, (1999), vol. 17, pages 2802 - 2816 | - COSTANTINO ET AL., VACCINE, (1999), vol. 17, pages 1251 - 1263 | - PARKHILL ET AL., NATURE, (2000), vol. 404, pages 502 - 506 | - TETTELIN ET AL., SCIENCE, (2000), vol. 287, pages 1809 - 1815 | - PIZZA ET AL., SCIENCE, (2000), vol. 287, pages 1816 - 1820 | - PEAK ET AL., FEMS IMMUNOL MED MICROBIOL, (2000), vol. 28, pages 329 - 334 | - COMANDUCCI ET AL., J. EXP. MED., (2002), vol. 195, pages 1445 - 1454 | - MASIGNANI ET AL., JEXP MED, (2003), vol. 197, pages 789 - 799 | - PETTERSSON ET AL., MICROB PATHOG, (1994), vol. 17, no. 6, pages 395 - 408 | - MAIDEN ET AL., PNAS USA, (1998), vol. 95, pages 3140 - 3145 | - GUSTAFSSON ET AL., N. ENGL. J. MED., (1996), vol. 334, pages 349 - 355 | - RAPPUOLI ET AL., TIBTECH, (1991), vol. 9, pages 232 - 238 | - BELL, PEDIATR INFECT DIS J, (2000), vol. 19, pages 1187 - 1188 | - IWARSON, APMIS, (1995), vol. 103, pages 321 - 326 | - GERLICH ET AL., VACCINE, (1990), vol. 8, pages S63 - 68,79-80 | - SUTTER ET AL., PEDIATR CLIN NORTH AM, (2000), vol. 47, pages 287 - 308 | - ZIMMERMAN; SPANN, AM FAM PHYSICIAN, (1999), vol. 59, pages 113 - 118,125-126 | - CHARALAMBOUS; FEAVERS, JMED MICROBIOL, (2001), vol. 50, pages 937 - 939 | - WESTERINK, INT REV IMMUNOL, (2001), vol. 20, pages 251 - 261 | - GROTHAUS ET AL., VACCINE, (2000), vol. 18, pages 1253 - 1263 | - KANRA ET AL., THE TURKISH JOURNAL OF PAEDIATRICS, (1999), vol. 42, pages 421 - 427 | - RAVENSCROFT ET AL., DEV BIOL (BASEL), (2000), vol. 103, pages 35 - 47 | - WATSON, PEDIATR INFECT DIS J, (2000), vol. 19, pages 331 - 332 | - RUBIN, PEDIATR CLIN NORTH AM, (2000), vol. 47, pages 269 - 285 | - JEDRZEJAS, MICROBIOL MOL BIOL REV, (2001), vol. 65, pages 187 - 207 | - ZIELEN ET AL., INFECT. IMMUN., (2000), vol. 68, pages 1435 - 1440 | - TETTELIN ET AL., SCIENCE, (2001), vol. 293, pages 498 - 506 | - HOSKINS ET AL., JBACTERIOL, (2001), vol. 183, pages 5709 - 5717 | - RAPPUOLI, CURR OPIN MICROBIOL, (2000), vol. 3, pages 445 - 450 | - RAPPUOLI, VACCINE, (2001), vol. 19, pages 2688 - 2691 | - MASIGNANI ET AL., EXPERT OPIN BIOL THER, (2002), vol. 2, pages 895 - 905 | - MORA ET AL., DRUG DISCOV TODAY, (2003), vol. 8, pages 459 - 464 | - WIZEMANN ET AL., INFECT IMMUN, (2001), vol. 69, pages 1593 - 1598 | - RIGDEN ET AL., CRIT REV BIOCHEM MOL BIOL, (2003), vol. 38, pages 143 - 168 | - PAOLETTI ET AL., VACCINE, (2001), vol. 19, pages 2118 - 2126 | - BARR ET AL., ADVANCED DRUG DELIVERY REVIEWS, (1998), vol. 32, pages 247 - 271 | - SJOLANDERET ET AL., ADVANCED DRUG DELIVERY REVIEWS, (1998), vol. 32, pages 321 - 338 | - NIIKURA ET AL., VIROLOGY, (2002), vol. 293, pages 273 - 280 | - LENZ ET AL., J IMMUNOL, (2001), vol. 166, pages 5346 - 5355 | - PINTO ET AL., J INFECT DIS, (2003), vol. 188, pages 327 - 338 | - GERBER ET AL., VIROL, (2001), vol. 75, pages 4752 - 4760 | - GLUCK ET AL., VACCINE, (2002), vol. 20, pages B10 - B16 | - JOHNSON ET AL., BIOORG MED CHEM LETT, (1999), vol. 9, pages 2273 - 2278 | - EVANS ET AL., EXPERT REV VACCINES, (2003), vol. 2, pages 219 - 229 | - MERALDI ET AL., VACCINE, (2003), vol. 21, pages 2485 - 2491 | - PAJAK ET AL., VACCINE, (2003), vol. 21, pages 836 - 842 | - KANDIMALLA ET AL., NUCLEIC ACIDS RESEARCH, (2003), vol. 31, pages 2393 - 2400 | - KRIEG, NATURE MEDICINE, (2003), vol. 9, pages 831 - 835 | - MCCLUSKIE ET AL., FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, (2002), vol. 32, pages 179 - 185 | - KANDIMALLA ET AL., BIOCHEMICAL SOCIETY TRANSACTIONS, (2003), vol. 31, pages 654 - 658 | - BLACKWELL ET AL., J IMMUNOL, (2003), vol. 170, pages 4061 - 4068 | - KRIEG, TRENDS IMMUNOL, (2002), vol. 23, pages 64 - 65 | - KANDIMALLA ET AL., BBRC, (2003), vol. 306, pages 948 - 953 | - BHAGAT ET AL., BBRC, (2003), vol. 300, pages 853 - 861 | - BEIGNON ET AL., INFECT IMMUN, (2002), vol. 70, pages 3012 - 3019 | - PIZZA ET AL., VACCINE, (2001), vol. 19, pages 2534 - 2541 | - PIZZA ET AL., INT J MED MICROBIOL, (2000), vol. 290, pages 455 - 461 | - SCHARTON-KERSTEN ET AL., INFECT IMMUN, (2000), vol. 68, pages 5306 - 5313 | - RYAN ET AL., INFECT IMMUN, (1999), vol. 67, pages 6270 - 6280 | - PARTIDOS ET AL., IMMUNOL LETT, (1999), vol. 67, pages 209 - 216 | - PEPPOLONI ET AL., EXPERT REV VACCINES, (2003), vol. 2, pages 285 - 293 | - PINE ET AL., J CONTROL RELEASE, (2002), vol. 85, pages 263 - 270 | - DOMENIGHINI ET AL., MOL MICROBIOL, (1995), vol. 15, pages 1165 - 1167 | - SINGH ET AL., J CONT RELEASE, (2001), vol. 70, pages 267 - 276 | - ANDRIANOV ET AL., BIOMATERIALS, (1998), vol. 19, pages 109 - 115 | - PAYNE ET AL., ADV DRUG DELIVERY REVIEW, (1998), vol. 31, pages 185 - 196 | - STANLEY, CLIN EXP DERMATOL, (2002), vol. 27, pages 571 - 577 | - JONES, CURR OPIN INVESTIG DRUGS, (2003), vol. 4, pages 214 - 218 | - ALMEIDA; ALPAR, J. DRUG TARGETING, (1996), vol. 3, pages 455 - 467 | - AGARWAL; MISHRA, INDIAN J EXP BIOL, (1999), vol. 37, pages 6 - 16 | - JAKOBSEN ET AL., INFECT IMMUN, (2002), vol. 70, pages 1443 - 1452 | - WU ET AL., J INFECT DIS, (1997), vol. 175, pages 839 - 846 | - BERGQUIST ET AL., APMIS, (1998), vol. 106, pages 800 - 806 | - BAUDNER ET AL., INFECT IMMUN, (2002), vol. 70, pages 4785 - 4790 | - UGOZZOLI ET AL., JLNFECT DIS, (2002), vol. 186, pages 1358 - 1361 | - SMITH; WATERMAN, ADV. APPL. MATH., (1981), vol. 2, pages 482 - 489 | GB20020023741 | GB20030005831 | GB20030009115 | GB20040008978 | GB20040008977 |